Nikhil Shah MBBS DNB(IM, Neph)🇨🇦
@dr_nikhilshah
Followers
4K
Following
14K
Media
1K
Statuses
13K
Nephrologist, Assoc Prof, PD Unit Director @UAlberta Prov Med Informatics Lead (PMIL) @HeyEpic #AI #LetsGoOilers
Edmonton, Canada
Joined May 2010
Some awards are well deserved. Here is @AdamRodmanMD winning the Innovation in Education Award!
1
2
25
Artificial intelligence, machine learning, telemedicine, and digital transformation in nephrology and transplantation #AI
@tandfonline @WeAreTandF @tandfnewsroom @tandfmedicine
https://t.co/OJbp1QW0k5 Charat Thongprayoon , Wannasit Wathanavasin & Wisit Cheungpasitporn
tandfonline.com
Published in Renal Failure (Vol. 47, No. 1, 2025)
0
10
11
AI has turned the doctor–patient dyad into a triad. Patients and clinicians now both consult chatbots, sometimes with life-or-death consequences. The new skill in medicine is learning to treat AI as a third participant in care. #MedEd
0
5
15
If you're not using AI for second opinion, you're doing medicine wrong I'd take a supervised CaBot over most doctors thinking de novo it'd fix so many errors in medicine TODAY Not in 5, 10, 20+ years https://t.co/M669mO6oFe
nejm.org
A 36-year-old man was admitted because of fever, hypoxemia, and bacteremia. Imaging revealed pulmonary opacities, thickening of the duodenal wall, and a thrombus in the right renal vein. A diagnosi...
1
2
12
AI guides are flooding the scene, but these top 9 picks from OpenAI, Google, and Anthropic are the ones you can't miss 🧵 ↓
6
23
92
Found this in my old saved screenshots on #falls So not sure who to credit but SO relevant 🙏🏾
5
15
104
Artificial intelligence, machine learning, telemedicine, and digital transformation in nephrology and transplantation @tandfonline @WeAreTandF @tandfnewsroom @tandfmedicine @wisit661
https://t.co/OJbp1QW0k5 Charat Thongprayoon , Wannasit Wathanavasin & Wisit Cheungpasitporn
tandfonline.com
Published in Renal Failure (Vol. 47, No. 1, 2025)
1
11
15
A concise viewpoint on how physicians can prepare for the generative A.I. era https://t.co/kX0BWwckpX
@JAMAInternalMed
3
84
276
How I manage MGUS in one Figure 👇
Management of Monoclonal Gammopathy of Undetermined Significance. In low-risk patients who are younger than 50 years of age, bone marrow biopsy and imaging may be considered a baseline evaluation, given the anticipated life expectancy. Learn more: https://t.co/OiMcemqVJg
6
79
254
One tool for each pillar. @Heptabase for your knowledge. @todoist for your tasks. @sunsamaHQ as a planner to schedule your time.
1
2
3
📢 The new #ISPD Position Paper on #Teaching #PeritonealDialysis is out! ✅ Open Access on the ISPD website & in #PDI Journal ✅ Updated guidance for #PD training, hybrid education, & post-training support. https://t.co/gDUStl7UEZ
#PDnurse #Nephrology #NephX
0
5
16
After what Connor McDavid did for @CityofEdmonton and for @Canada today, WHEN (not if) we win the Cup, Whyte Avenue should be re-named "McDavid Avenue". Thanks McJesus, you gave us a fighting chance. 🙏 #LetsGoOilers #McDavidAvenue
#Thisistheway
0
0
2
Just out in the New England Journal of Medicine! Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM
https://t.co/vu9REOKBPS 5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and
21
261
886
It's #WorldPodcastDay! Podcasts have become a key communication tool. Join us at #PDExchange, a podcast where we review the latest research in #PeritonealDialysis with world experts. We focus on the latest articles from @PDI_Journal (& other journals) https://t.co/X23kignA8r
1
1
2
Don't forget to hit the subscribe button on your favorite podcast platform! Spotify: https://t.co/X9oHPcBBzk Google Podcasts: https://t.co/oSIcDtTVN0 Apple Podcasts: https://t.co/l2YfXUa6Sy
0
1
2
Here we go. Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis
journals.sagepub.com
Peritoneal dialysis (PD) has important disadvantages compared to hemodialysis, including low plasma clearance and limited technique survival. A new device for s...
0
2
6
Now open access in @NDTsocial QT-Prolonging Medications: Prevalence of Use and Associated Risks in CKD 🧐The pathophysiological relevance, prevalence, and CV consequences of QT-prolonging drug use in the CKD setting ▶️ https://t.co/rkyfHf3QRw
2
24
56
🌟 Grateful and honored to provide an educational discussion today on “How to Critically Appraise AI and Machine Learning Studies in Nephrology – Best Practice 2025.” #AI #MachineLearning #Nephrology #MedicalEducation Many thanks to Dr. Bouchard, Deputy Editor of the Canadian
1
20
45